Form 4: OptimizeRx Corp Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Marion Odence-Ford, Chief Legal Officer & CHRO of OptimizeRx Corp, disposed of shares to cover tax withholding obligations.
Summary
- On February 15, 2025, Marion Odence-Ford, the Chief Legal Officer & CHRO of OptimizeRx Corp, disposed of 1,479 shares of common stock to satisfy tax withholding obligations.
- The shares were sold at a price of $6.64 per share.
- Following the transaction, Odence-Ford beneficially owns 69,773 shares of OptimizeRx Corp.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an insider transaction for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for insider sales.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders, as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/15/2025 | Date of transaction: Marion Odence-Ford disposed of shares. |
| 02/20/2025 | Date of signature on the Form 4 filing. |
Keywords
OptimizeRx Corp, OPRX, Form 4, SEC Filing, Insider Trading, Stock Sale, Tax Withholding, Marion Odence-Ford, Chief Legal Officer, CHRO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.